A Dual Disease State TAVR SolutionJenaValve is a clinical-stage medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of both severe aortic regurgitation and stenosis. JenaValve is passionate about providing our physician partners with cutting edge technology aimed at improving the lives of our patients.